Anna Horova

539 total citations
21 papers, 464 citations indexed

About

Anna Horova is a scholar working on Pharmacology, Computational Theory and Mathematics and Plant Science. According to data from OpenAlex, Anna Horova has authored 21 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pharmacology, 10 papers in Computational Theory and Mathematics and 10 papers in Plant Science. Recurrent topics in Anna Horova's work include Cholinesterase and Neurodegenerative Diseases (19 papers), Computational Drug Discovery Methods (10 papers) and Pesticide Exposure and Toxicity (10 papers). Anna Horova is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (19 papers), Computational Drug Discovery Methods (10 papers) and Pesticide Exposure and Toxicity (10 papers). Anna Horova collaborates with scholars based in Czechia, Serbia and Russia. Anna Horova's co-authors include Kamil Kuča, Kamil Musílek, Jan Korábečný, Vendula Šepsová, Eugenie Nepovimová, Rafael Doležal, Ondřej Soukup, Daniel Jun, Martin Andrš and Katarína Špilovská and has published in prestigious journals such as Journal of Medicinal Chemistry, Molecules and European Journal of Medicinal Chemistry.

In The Last Decade

Anna Horova

21 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Horova Czechia 10 371 223 175 117 82 21 464
Ľubica Múčková Czechia 13 383 1.0× 236 1.1× 202 1.2× 152 1.3× 112 1.4× 38 588
Petr Jošt Czechia 10 255 0.7× 171 0.8× 132 0.8× 97 0.8× 83 1.0× 20 427
Tuba Tüylü Küçükkılınç Türkiye 16 417 1.1× 280 1.3× 402 2.3× 82 0.7× 152 1.9× 42 763
José Dias France 13 235 0.6× 128 0.6× 96 0.5× 119 1.0× 176 2.1× 29 454
Vendula Hepnarová Czechia 11 204 0.5× 117 0.5× 117 0.7× 87 0.7× 58 0.7× 26 309
Arie Lazar Israel 5 336 0.9× 232 1.0× 133 0.8× 133 1.1× 114 1.4× 5 401
Olga G. Serebryakova Russia 14 360 1.0× 247 1.1× 349 2.0× 53 0.5× 141 1.7× 36 581
Natilie A. Pickering United States 4 666 1.8× 413 1.9× 194 1.1× 289 2.5× 214 2.6× 4 740
Marie‐Thérèse Froment France 13 284 0.8× 167 0.7× 99 0.6× 253 2.2× 146 1.8× 14 512
Petra Kapková Germany 8 235 0.6× 157 0.7× 154 0.9× 45 0.4× 133 1.6× 11 400

Countries citing papers authored by Anna Horova

Since Specialization
Citations

This map shows the geographic impact of Anna Horova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Horova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Horova more than expected).

Fields of papers citing papers by Anna Horova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Horova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Horova. The network helps show where Anna Horova may publish in the future.

Co-authorship network of co-authors of Anna Horova

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Horova. A scholar is included among the top collaborators of Anna Horova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Horova. Anna Horova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kuča, Kamil, Jana Žďárová Karasová, Ondřej Soukup, et al.. (2018). Development of small bisquaternary cholinesterase inhibitors as drugs for pre-treatment of nerve agent poisonings. Drug Design Development and Therapy. Volume 12. 505–512. 5 indexed citations
2.
Kassa, Jiřı́, Vendula Šepsová, Anna Horova, & Kamil Musílek. (2016). A comparison of the reactivating and therapeutic efficacy of two novel bispyridinium oximes (K305, K307) with the oxime K203 and trimedoxime in tabun-poisoned rats and mice. Journal of Applied Biomedicine. 15(1). 49–53. 2 indexed citations
3.
4.
Nepovimová, Eugenie, Jan Korábečný, Rafael Doležal, et al.. (2015). Tacrine–Trolox Hybrids: A Novel Class of Centrally Active, Nonhepatotoxic Multi-Target-Directed Ligands Exerting Anticholinesterase and Antioxidant Activities with Low In Vivo Toxicity. Journal of Medicinal Chemistry. 58(22). 8985–9003. 113 indexed citations
5.
Korábečný, Jan, Martin Andrš, Eugenie Nepovimová, et al.. (2015). 7-Methoxytacrine-p-Anisidine Hybrids as Novel Dual Binding Site Acetylcholinesterase Inhibitors for Alzheimer’s Disease Treatment. Molecules. 20(12). 22084–22101. 38 indexed citations
6.
Kassa, Jiřı́, Vendula Šepsová, Anna Horova, & Kamil Musílek. (2015). A comparison of the reactivating and therapeutic efficacy of two novel bispyridinium oximes (K920, K923) with the oxime K203 and trimedoxime in tabun-poisoned rats and mice. Journal of Applied Biomedicine. 13(4). 299–304. 1 indexed citations
7.
Park, Min Kyun, Dae Won Cho, Choon Sup, et al.. (2015). Preparation of 7‐Methoxy Tacrine Dimer Analogs and Their In vitro/In silico Evaluation as Potential Cholinesterase Inhibitors. Bulletin of the Korean Chemical Society. 36(6). 1654–1660. 9 indexed citations
8.
Korábečný, Jan, Rafael Doležal, Anna Horova, et al.. (2014). 7-MEOTA–donepezil like compounds as cholinesterase inhibitors: Synthesis, pharmacological evaluation, molecular modeling and QSAR studies. European Journal of Medicinal Chemistry. 82. 426–438. 71 indexed citations
9.
Benek, Ondřej, Kamil Musílek, Anna Horova, et al.. (2014). Preparation, In Vitro Screening and Molecular Modelling of Monoquaternary Compounds Related to the Selective Acetylcholinesterase Inhibitor BW284c51. Medicinal Chemistry. 11(1). 21–29. 4 indexed citations
10.
Kassa, Jiřı́, et al.. (2014). A Comparison of the Reactivating and Therapeutic Efficacy of Two Newly Developed Oximes (K727 and K733) with Oxime K203 and Trimedoxime in Tabun‐Poisoned Rats and Mice. Basic & Clinical Pharmacology & Toxicology. 116(4). 367–371. 9 indexed citations
11.
Horova, Anna, Martina Hrabinová, Daniel Jun, et al.. (2013). Preparation, in vitro evaluation and molecular modelling of pyridinium–quinolinium/isoquinolinium non-symmetrical bisquaternary cholinesterase inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(24). 6663–6666. 14 indexed citations
12.
13.
Špilovská, Katarína, Jan Korábečný, Jan Král, et al.. (2013). 7-Methoxytacrine-Adamantylamine Heterodimers as Cholinesterase Inhibitors in Alzheimer’s Disease Treatment — Synthesis, Biological Evaluation and Molecular Modeling Studies. Molecules. 18(2). 2397–2418. 61 indexed citations
14.
Korábečný, Jan, Ladislav Janovec, Kamil Musílek, et al.. (2013). Comparison of Novel Tacrine and 7-MEOTA Derivatives with Aromatic and Alicyclic Residues: Synthesis, Biological Evaluation and Docking Studies. Letters in Organic Chemistry. 10(4). 291–297. 4 indexed citations
15.
Musílek, Kamil, et al.. (2012). Myasthenia Gravis – Current Treatment Standards and Emerging Drugs. InTech eBooks. 60(2). 47–53. 1 indexed citations
16.
Holas, Ondřej, Kamil Musílek, Anna Horova, Veronika Opletalová, & Kamil Kuča. (2012). SAR Study on Reactivators of Ethyl-Paraoxon Inhibited Acetylcholinesterase. Letters in Drug Design & Discovery. 9(6). 587–594. 1 indexed citations
17.
Kassa, Jiřı́, Vendula Šepsová, Kamil Musílek, & Anna Horova. (2012). The evaluation of the reactivating and therapeutic efficacy of three novel bispyridinium oximes (K454, K456, K458) in comparison with the oxime K203 and trimedoxime in tabun-poisoned rats and mice. Toxicology Mechanisms and Methods. 23(2). 94–98. 4 indexed citations
18.
Musílek, Kamil, Anna Horova, Ondřej Holas, et al.. (2011). Preparation, in vitro screening and molecular modelling of symmetrical bis-quinolinium cholinesterase inhibitors—implications for early Myasthenia gravis treatment. Bioorganic & Medicinal Chemistry Letters. 21(8). 2505–2509. 32 indexed citations
19.
Korábečný, Jan, Kamil Musílek, Filip Zemek, et al.. (2011). Synthesis and in vitro evaluation of 7-methoxy-N-(pent-4-enyl)-1,2,3,4-tetrahydroacridin-9-amine—new tacrine derivate with cholinergic properties. Bioorganic & Medicinal Chemistry Letters. 21(21). 6563–6566. 20 indexed citations
20.
Musílek, Kamil, Ondřej Holas, Anna Horova, et al.. (2010). Mono-oxime bisquaternary acetylcholinesterase reactivators with prop-1,3-diyl linkage—Preparation, in vitro screening and molecular docking. Bioorganic & Medicinal Chemistry. 19(2). 754–762. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ľubica Múčková Breakdown of academic impact, for papers by Petr Jošt Breakdown of academic impact, for papers by Tuba Tüylü Küçükkılınç Breakdown of academic impact, for papers by José Dias Breakdown of academic impact, for papers by Vendula Hepnarová Breakdown of academic impact, for papers by Arie Lazar Breakdown of academic impact, for papers by Olga G. Serebryakova Breakdown of academic impact, for papers by Natilie A. Pickering Breakdown of academic impact, for papers by Marie‐Thérèse Froment Breakdown of academic impact, for papers by Petra Kapková
Rankless by CCL
2026